Evidence map›Paper›PMID 25317702›Full record

ArticleMemorias do Instituto Oswaldo Cruz2014

Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure.

Ana Carolina Urbaczek, Lívia Carolina de Abreu Ribeiro, Valdecir Farias Ximenes, Ana Afonso, Camila Tita Nogueira, Wesley Cardoso Generoso, Juliana Vieira Alberice, Martina Rudnicki, Renila Ferrer, Luiz Marcos da Fonseca and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  2. Review
  3. Article
  4. Article
  5. Hepatitis C virus and cardiovascular: A review.Journal of advanced research · 2017
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Ana Carolina UrbaczekLaboratório de Imunologia Clínica, Departamento de Análises Clínicas, Escola de Ciências Farmacêuticas, Bauru, SP, Brasil.
Lívia Carolina de Abreu RibeiroLaboratório de Imunologia Clínica, Departamento de Análises Clínicas, Escola de Ciências Farmacêuticas, Bauru, SP, Brasil.
Valdecir Farias XimenesDepartamento de Química, Faculdade de Ciências, Universidade Estadual Paulista Julio de Mesquita Filho, Bauru, SP, Brasil.
Ana AfonsoUnidade de Parasitologia Médica e Microbiologia, Departamento de Parasitologia Médica, Instituto de Higiene e Medicina Tropcal, Universidade Nova de Lisboa, Lisboa, Portugal.
Camila Tita NogueiraLaboratório de Imunologia Clínica, Departamento de Análises Clínicas, Escola de Ciências Farmacêuticas, Bauru, SP, Brasil.
Wesley Cardoso GenerosoDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brasil.
Juliana Vieira AlbericeGrupo de Bioanalítica, Microfabricações e Separações, Departamento de Química e Física Molecular, Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP, Brasil.
Martina RudnickiEscola de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP, Brasil.
Renila FerrerEscola de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP, Brasil.
Luiz Marcos da FonsecaLaboratório de Imunologia Clínica, Departamento de Análises Clínicas, Escola de Ciências Farmacêuticas, Bauru, SP, Brasil.
Paulo Inácio da CostaLaboratório de Imunologia Clínica, Departamento de Análises Clínicas, Escola de Ciências Farmacêuticas, Bauru, SP, Brasil.
Instituto de Ciências Farmacêuticas · BRUniversidade de São Paulo · BRUniversidade Brasil · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal de São Carlos · BRUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hepatitis C virus (HCV) encodes approximately 10 different structural and non-structural proteins, including the envelope glycoprotein 2 (E2). HCV proteins, especially the envelope proteins, bind to cell receptors and can damage tissues. Endothelial inflammation is the most important determinant of fibrosis progression and, consequently, cirrhosis. The aim of this study was to evaluate and compare the inflammatory response of endothelial cells to two recombinant forms of the HCV E2 protein produced in different expression systems (Escherichia coli and Pichia pastoris). We observed the induction of cell death and the production of nitric oxide, hydrogen peroxide, interleukin-8 and vascular endothelial growth factor A in human umbilical vein endothelial cells (HUVECs) stimulated by the two recombinant E2 proteins. The E2-induced apoptosis of HUVECs was confirmed using the molecular marker PARP. The apoptosis rescue observed when the antioxidant N-acetylcysteine was used suggests that reactive oxygen species are involved in E2-induced apoptosis. We propose that these proteins are involved in the chronic inflammation caused by HCV.

Indexed as

ApoptosisArginaseCell SurvivalEscherichia coliFibrosisGene ExpressionGenetic EngineeringGenetic VectorsHepacivirusHepatitis C AntigensHumansHuman Umbilical Vein Endothelial CellsInflammationInterleukin-8Nitric OxidePichiaArginaseglycoprotein E2, Hepatitis C virusHepatitis C AntigensInterleukin-8Nitric OxideRecombinant ProteinsTumor Necrosis Factor-alphaVascular Endothelial Growth Factor AViral Envelope Proteins

Identifiers

PMID25317702
PMCPMC4238766
OpenAlexW2132643285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.